Event: DIA Webinar 2025
Date: Nov 12,2025
Time: 12:00 PM - 1:00 PM EST
Location: Online (Live Webinar)
Invitation:
This webinar offers a rare, high-value opportunity for audiences to hear directly from top-10 global pharma, AlphaLife Sciences as the solution enabler, and Microsoft on the future of AI in regulatory and medical authoring. The session features Microsoft’s perspective on harnessing AI to reclaim time for scientific thinking, enable knowledge mining, and accelerate discovery. Attendees will experience enterprise-grade, agentic AI solutions, including auto-templating and scalable workflows that cover the full spectrum of document types such as ICF, Protocol, SAP, CSR, DSUR/PBRER, and CTD Module 2.7.x. A live demo will showcase end-to-end document automation with built-in QC in Microsoft Word and Veeva RIM, complemented by agent-based platforms for enterprise customization. The panel discussion brings together pharma experts to share practical insights on business value, adoption challenges, solution requirements, and change-management practices for AI at scale, —giving you direct insight into what’s working and how to accelerate your own roadmap confidently
Webinar Information：
Topic：How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with Quality Control
Register：https://connect.diaglobal.org/alphalife-sciences-webinar-registration
Featured topics:
Microsoft perspective: AI in pharma—reclaim time for scientific thinking, enable knowledge mining, and accelerate discovery.
Enterprise-grade scalable solutions: auto-template via agentic AI, supporting scalability across all document types, including ICF, Protocol, SAP, CSR, DSUR/PBRER, CTD Module 2.7.x, and more.
Agentic AI platform for developers: AI agent-based workflows enabling enterprise-customized documents and workflows.
End-to-end document automation software demo: regulatory and medical authoring with built-in QC—directly in Microsoft Word and Veeva RIM.
Panel with top pharma: proven business value, enterprise barriers to adoption, solution requirements for regulatory documentation, and change-management practices for scale.
Target audience:
Drug R&D Leaders
Clinical Development Leaders
Regulatory Affairs Professionals
Medical Writers and Leaders
Regulatory Technical Authors
Labeling Professionals
Regulatory Compliance Professionals
Medical Affairs Professionals
Clinical Safety/Pharmacovigilance Experts
AI / Digital Innovation Leaders
IT Professionals
Speakers：
Sharon Chen，Founder and CEO，AlphaLife Sciences
John Jenkins，Former Director of Office of New Drugs at FDA. Former Principal of Drug and Biological Products at Greenleaf Health
Ellis Unger，Former Director of Cardiology, Hematology, Endocrinology, and Nephrology (OCHEN) at FDA.
Darren Weston，Head, Integrated Data Analytics & Reporting，Johnson & Johnson
Neil Garrett，Head of Regulatory Medical Writing，Johnson & Johnson
Eunice Youhanna，Industry Advisor, Health & Life Sciences，Microsoft
To request a meeting, fill out the form provided and a representative will be in contact soon to schedule.
